Accelerating Innovation: Integrated Oligonucleotides and Peptides Solutions
From discovery-scale peptide synthesis to commercial oligonucleotide synthesis, Syngene’s integrated DS/DP program accelerates your path to the clinic.
Talk to our Technical Experts
The Power of Integration
Why navigate fragmented supply chains?
We integrate peptide development and manufacturing under a single, unified quality system to eliminate bottlenecks.
Parallel Workflows:
Conduct process development and analytical validation simultaneously to shave months off your timeline.
Knowledge Consolidation:
Seamless data sharing between teams reduces tech-transfer risks and ensures consistency.
Clinical Readiness:
Transition from Engineering to GMP Clinical batches in as little as 12 months.
Comprehensive Oligonucleotide Services
Our platform offers seamless oligonucleotide synthesis using industry-leading K&A H16 and GE ÄKTA systems. We support diverse modalities, ensuring high purity and yield at every scale.
Advanced Peptide Expertise
Our platform offers seamless oligonucleotide synthesis using industry-leading K&A H16 and GE ÄKTA systems. We support diverse modalities, ensuring high purity and yield at every scale.
End-to-End Analytical & Support
Our “Support Beyond Synthesis” philosophy ensures your drug substance is robust, stable, and compliant with global standards.
Structural Analysis:
Dedicated facilities for rigorous physicochemical characterization.
Impurity Profiling:
Expert bioburden and impurity analysis to meet stringent regulatory requirements.
Formulation & Fill-Finish:
Specialized capabilities for Small Volume Parenterals (SVPs) and complex delivery formats.
The Future is Scaling in Mangalore
Something significant is unfolding at our facility in MSEZ. We are strategically evolving our peptide/oligo manufacturing footprint, building the next generation of commercial-scale infrastructure.
With future-ready ISO-8 and ISO-7 cleanroom spaces already in motion, we are redefining what “scale” means for the industry.